当前位置: X-MOL 学术Lancet Global Health › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Evidence for visceral leishmaniasis elimination in Nepal.
The Lancet Global Health ( IF 19.9 ) Pub Date : 2020-02-01 , DOI: 10.1016/s2214-109x(19)30538-8
Megha Raj Banjara 1 , Anand Ballabh Joshi 2
Affiliation  

Visceral leishmaniasis is an important public health problem in Nepal. In 2005, Bangladesh, India, and Nepal signed a memorandum of understanding to eliminate visceral leishmaniasis in this region by 2015. As the elimination target was not reached in 2015, the date has been extended to 2020. The visceral leishmaniasis elimination strategy emphasised early case detection, effective treatment, integrated vector management, and reduced transmission. Although Nepal achieved elimination targets in all 12 visceral leishmaniasis endemic districts from 2013 and thereafter, one of the previously non-endemic districts crossed the elimination target in 2017, however, this achieved target is not sustainable. A substantial reduction of visceral leishmaniasis incidence has been observed in the Indian subcontinent and Nepal has reduced its visceral leishmaniasis incidence by 90% compared with 2005. Despite this progress, the disease has now been reported in new ecological niches and hilly districts of Nepal in which there is no visceral leishmaniasis control programme.

中文翻译:

尼泊尔消除内脏利什曼病的证据。

内脏利什曼病是尼泊尔的重要公共卫生问题。2005年,孟加拉国,印度和尼泊尔签署了一项谅解备忘录,以在2015年前消除该地区的内脏利什曼病。由于在2015年未达到消除目标,该日期已延长至2020年。内脏利什曼病消灭策略强调早期病例检测,有效治疗,综合病媒管理和减少传播。尽管尼泊尔从2013年及其后的所有12个内脏利什曼病地方病地区均实现了消灭目标,但先前非疫区之一在2017年超过了消灭目标,但是,这一实现的目标并不可持续。, 
更新日期:2020-01-23
down
wechat
bug